SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

AbbVie Raises Annual Profit Forecast as Immunology Drugs Fuel Growth

AbbVie lifted its annual profit forecast, citing continued growth from its immunology drugs.

ABBV
SquawkNews Desk 1 updates Updated Oct 30, 2026, 04:02 PM UTC

Story updates

04:02:34 PM UTC
SquawkNews
11:59 AM EDT, 10/30/2026 (MT Newswires) -- AbbVie (ABBV) raised its 2026 guidance on Friday as the b

Related stories

U.S. Stocks Extend Fall; Nasdaq Down 3.00% M impact | EQUITY | Oct 30, 2026, 04:51 PM UTC UBS Sees Eli Lilly Sustaining Obesity Growth UBS said Eli Lilly's strong results and higher guidance support continued obesity growth. M impact | EQUITY | Oct 30, 2026, 04:50 PM UTC Anthropic may not secure investment-grade rating after IPO, Blackstone tells investors - FT L impact | EQUITY | Oct 30, 2026, 04:47 PM UTC Charles Schwab Shares Hit 18-week Low Charles Schwab shares decreased to 88.11 USD, the lowest since June 2026. Over the past 4 weeks, Charles Schwab lost 10.38%, and in the last 12 months, it decreased 6.73%. L impact | EQUITY | Oct 30, 2026, 04:46 PM UTC Nasdaq Composite Falls 688.54 Points (2.63%) M impact | EQUITY | Oct 30, 2026, 04:45 PM UTC S&P 500 falls 122.14 points (1.58%) M impact | EQUITY | Oct 30, 2026, 04:45 PM UTC